Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03180736 |
|---|---|
| Brief Title: | Comparison of Pomalidomide and Dexamethasone With or Without Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Previously Treated With Lenalidomide and a Proteasome InhibitorDaratumumab/Pomalidomide/Dexamethasone vs Pomalidomide/Dexamethasone (EMN14) |
| First Submitted : | May 30, 2017 |
| First Submitted that Met QC Criteria : | June 7, 2017 |
| First Posted : | June 8, 2017 |
| Results First Submitted : | April 13, 2021 |
| Results First Submitted that Met QC Criteria : | February 22, 2022 |
| Results First Posted : | May 11, 2022 |
| Last Update Submitted that Met QC Criteria : | February 22, 2022 |
| Last Update Posted : | May 11, 2022 |